MedTrace Logo

Influence of Neuromuscular Block on Mask Ventilation

NCT01849211 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-02-21

No results posted yet for this study

Summary

Difficult mask ventilation might lead to a life-threatening situation, if endotracheal intubation is also impossible and neuromuscular blocking agents (NMBA) inhibit spontaneous ventilation. However, controversies exist if NMBA improve or impede face mask ventilation. Therefore, the effect of NMBAs on mask ventilation is assessed in patients with predictors for difficult face mask ventilation.

Conditions

  • Effect of a Neuromuscular Block on Ventilation

Interventions

DRUG

rocuronium

Sponsors & Collaborators

  • Kreiskrankenhaus Dormagen

    lead OTHER

Principal Investigators

  • Stefan Soltesz, MD · KKH Dormagen

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2017-04-30
Completion
2018-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01849211 on ClinicalTrials.gov